SCHEMBL3399546

SCHEMBL3399546

Cc1nc(-c2ccc(C#N)cc2)sc1C(=O)NC1CCN(C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 9/20 0.48
EGLN1 Q9GZT9 2/20 0.48
PPARD Q03181 5/20 0.47
PPARG P37231 2/20 0.47
CNR1 P21554 1/20 0.46
PRKAA2 P54646 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
CCNT1 O60563 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CDK7 P50613 1/20 0.44
CDK9 P50750 1/20 0.44
CCNH P51946 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MKNK2 Q9HBH9 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3400002 0.85 PPARA (0.54) PPARAPPARDPPARGCNR1SMN1; SMN2
SCHEMBL3404075 0.84 PPARA (0.58) PPARAPPARDPPARGCNR1SMN1; SMN2
SCHEMBL3402266 0.84 PPARA (0.49) PPARAPPARDPPARGCNR1SMN1; SMN2
SCHEMBL3403484 0.84 PPARA (0.49) PPARAPPARDPPARGCNR1ALDH1A1
SCHEMBL13071969 0.83 CHRM4 (0.54) PPARAPPARDPPARGCNR1SMN1; SMN2
SCHEMBL3402398 0.83 NPC1 (0.62) PPARAPPARDPPARGALDH1A1GAA
SCHEMBL3405227 0.82 PPARA (0.48) PPARAPPARDPPARGCNR1HPGD
SCHEMBL3401401 0.82 PPARA (0.53) PPARAPPARDPPARGCNR1SMN1; SMN2
SCHEMBL3404893 0.81 PPARA (0.50) PPARAPPARDPPARGCNR1SMN1; SMN2
SCHEMBL3399603 0.81 PPARA (0.55) PPARAPPARDPPARGCNR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues LIGAND PHARMACEUTICALS, INC. (US) 2010-11-25 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
WO-2006089076-A9 THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES NEUROGEN CORP (US) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues HRH3, HRH4, HRH2 PPARA 492/4885EGLN1 974/4885PPARD 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.